NASACORT ALLERGY 24 HOUR Drug Patent Profile
✉ Email this page to a colleague
When do Nasacort Allergy 24 Hour patents expire, and when can generic versions of Nasacort Allergy 24 Hour launch?
Nasacort Allergy 24 Hour is a drug marketed by Chattem Sanofi and is included in one NDA.
The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasacort Allergy 24 Hour
A generic version of NASACORT ALLERGY 24 HOUR was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for NASACORT ALLERGY 24 HOUR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 8 |
Patent Applications: | 3,176 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NASACORT ALLERGY 24 HOUR at DailyMed |
Recent Clinical Trials for NASACORT ALLERGY 24 HOUR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gail Gauvreau | N/A |
Stanford University | Phase 4 |
Sanofi | Phase 4 |
Pharmacology for NASACORT ALLERGY 24 HOUR
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for NASACORT ALLERGY 24 HOUR
US Patents and Regulatory Information for NASACORT ALLERGY 24 HOUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NASACORT ALLERGY 24 HOUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NASACORT ALLERGY 24 HOUR
See the table below for patents covering NASACORT ALLERGY 24 HOUR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 9800178 | ⤷ Try a Trial | |
China | 1228712 | ⤷ Try a Trial | |
Poland | 194269 | ⤷ Try a Trial | |
Australia | 737506 | ⤷ Try a Trial | |
South Korea | 100383601 | ⤷ Try a Trial | |
Australia | 3647197 | ⤷ Try a Trial | |
Hungary | 9903503 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |